366 related articles for article (PubMed ID: 17193857)
21. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting].
Gerasimchuk EV; Gerasimov VV; Molchanov BA
Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907
[No Abstract] [Full Text] [Related]
22. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
[TBL] [Abstract][Full Text] [Related]
23. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial.
Kaçar N; Ergin S; Ergin C; Erdogan BS; Kaleli I
Clin Exp Dermatol; 2007 Jan; 32(1):1-5. PubMed ID: 16824053
[TBL] [Abstract][Full Text] [Related]
24. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
Ginter-Hanselmayer G; Weger W; Smolle J
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
[TBL] [Abstract][Full Text] [Related]
25. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
[TBL] [Abstract][Full Text] [Related]
26. [How to improve efficacy of onychomycosis treatment?].
Nowicki R
Wiad Parazytol; 2001; 47(4):823-32. PubMed ID: 16886434
[TBL] [Abstract][Full Text] [Related]
27. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
Grover C; Bansal S; Nanda S; Reddy BS; Kumar V
Br J Dermatol; 2007 Aug; 157(2):364-8. PubMed ID: 17573877
[TBL] [Abstract][Full Text] [Related]
28. The uptake of fluconazole in finger and toe nails.
Laufen H; Zimmermann T; Yeates RA; Schumacher T; Wildfeuer A
Int J Clin Pharmacol Ther; 1999 Jul; 37(7):352-60. PubMed ID: 10442510
[TBL] [Abstract][Full Text] [Related]
29. [Ketoconazole and onychomycosis].
Parent D; Achten G; André J; Wiame L
Ann Dermatol Venereol; 1984; 111(4):339-44. PubMed ID: 6089641
[TBL] [Abstract][Full Text] [Related]
30. [A clinical trial and the prospects for the Orungal therapy of onychomycoses].
Tarasenko GN; Patronov IV; Tarasenko IuG
Voen Med Zh; 1999 Jun; 320(6):37-9. PubMed ID: 10439713
[No Abstract] [Full Text] [Related]
31. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.
Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S
J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989
[TBL] [Abstract][Full Text] [Related]
32. [New treatments of onychomycoses].
Baran R
Ann Dermatol Venereol; 1992; 119(3):227-31. PubMed ID: 1318667
[No Abstract] [Full Text] [Related]
33. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
Lecha M
Br J Dermatol; 2001 Oct; 145 Suppl 60():21-6. PubMed ID: 11777261
[TBL] [Abstract][Full Text] [Related]
34. Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study.
Assaf RR; Elewski BE
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):216-9. PubMed ID: 8708024
[TBL] [Abstract][Full Text] [Related]
35. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
[TBL] [Abstract][Full Text] [Related]
36. Two novel itraconazole pulse therapies for onychomycosis: a 2-year follow-up.
Avner S; Nir N; Baruch K; Henri T
J Dermatolog Treat; 2006; 17(2):117-20. PubMed ID: 16766337
[TBL] [Abstract][Full Text] [Related]
37. Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis.
Warrick D; Church L
J Fam Pract; 1999 Jul; 48(7):492-3. PubMed ID: 10428238
[No Abstract] [Full Text] [Related]
38. Toenail onychomycosis: current and future treatment options.
Finch JJ; Warshaw EM
Dermatol Ther; 2007; 20(1):31-46. PubMed ID: 17403258
[TBL] [Abstract][Full Text] [Related]
39. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
Shemer A; Nathansohn N; Kaplan B; Trau H
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):279-82. PubMed ID: 18269594
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of fluconazole at a 400 mg weekly dose for the treatment of onychomycosis.
Hryncewicz-Gwóźdź A; Plomer-Niezgoda E; Kalinowska K; Czarnecka A; Maj J; Jagielski T
Acta Derm Venereol; 2015 Feb; 95(2):251-2. PubMed ID: 24942666
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
